Open AccessMeta-analysis on the risk of fatal adverse events by bevacizumab, cetuximab, and panitumumab in 31 randomized trials including 25,000 patients with colorectal carcinoma
Author(s) -
Jianxin Chen,
Junhui Wang,
Tao Ni,
Hang He,
Qinhong Zheng
Publication year - 2020
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000019908
Subject(s) - cetuximab , medicine , bevacizumab , panitumumab , colorectal cancer , oncology , adverse effect , meta analysis , randomized controlled trial , cochrane library , relative risk , confidence interval , cancer , chemotherapy